GSK PLC

Related company / holding

Theravance Biopharma, Inc.Wave Life Sciences Ltd.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 1 buy · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (3 ops.)

€59.2M

▼ Sales (0 ops.)

—

Latest filing published 15 Dec 2025 for Wave Life Sciences Ltd., €23.9M. Read the official filing

Filing timeline

BuySale

GSK PLC

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Wave Life Sciences Ltd. 3 purchases · last 15 Dec 2025

Since each purchase

Wave Life Sciences Ltd.
Filed 15 Dec 2025 · 307 days ago · €23.9M
-24.4%
Entry US$16.41 · Close at T+90 US$12.41

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

GSK PLC: trading record in brief

GSK PLC has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Wave Life Sciences Ltd. and Theravance Biopharma, Inc. The record holds 4 filings, for trades running from 16 September 2022 to 11 December 2025.

The open-market record is one-sided, with 3 purchases worth €59.2M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2025 to date brings 1 purchase and no sales.

Half of the purchases are above €20.0M and half below. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 15 December 2025: an open-market purchase of €23.9M, in Wave Life Sciences Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.